Sbir phase II: novel system for diagnosis of vision disorders
Ended Cooperative Agreement Awarded Last action
- Award ID
- 2051797
- Recipient
-
Oculomotor Technologies Inc. UEI XJ17ZWMBBKV9
- Awarding agency
-
National Science Foundation
- Obligated
- $1,000,000
Award facts
- Assistance listing
- 47.084 NSF Technology, Innovation, and Partnerships
- Completion date
- Place of performance
- Newark, NJ 07103, USA
Award details come from USAspending.gov.
About this award
Oculomotor Technologies Inc. was awarded a $1,000,000 cooperative agreement from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel system for diagnosis of vision disorders. The two-year award, issued on May 1, 2021 with a completion date of April 30, 2023, will support Oculomotor Technologies' efforts to advance science and engineering research leading to breakthrough technologies for solutions to national challenges. Specifically, the company will work to develop an innovative technology for diagnosing vision disorders that could help improve detection and treatment of eye diseases. The work will be performed in Newark, New Jersey.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $1,000,000 |
Quick answers
Who received award 2051797?
2051797 was awarded to Oculomotor Technologies Inc. by National Science Foundation on May 1, 2021.
How much is award 2051797 worth?
$1,000,000 has been obligated on 2051797.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award